International   

Human bird flu vaccine

BEIJING: China's drug watchdog on Tuesday approved its home-made human bird flu vaccine for clinical tests, a major progress in the prevention efforts of possible pandemic. The vaccine was developed from the NIBRG-14 virus strain recommended and provided by WHO, according to the State Food and Drug Administration (SFDA). Pre-clinical trials show the vaccine is fairly safe and effective and the virus strain and the producing procedures are reliable, said SFDA experts. China began developing the vaccine last year. China has so far reported 21 bird flu outbreaks in nine provinces, and municipalities, and has confirmed two human cases. — Xinhua

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

Move to amend Japan's pacifist Constitution
Merkel takes over as Chancellor
White House changes tack
Chavez blames Bush for spat with Mexico
How affection helps
For a journey to the edge of space
Rice denies role in leak of CIA agent's identity
Bush's remarks assailed
Kibaki admits defeat
Human bird flu vaccine
Pakistan regrets `evasive response' of India
Marketing "Asian brands" engages participants at meeting

Copyright © 2005, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu